Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.8K Hold
20
0.01% 216
2026
Q1
$26.4K Hold
20
﹤0.01% 227
2025
Q4
$21.4K Hold
20
﹤0.01% 228
2025
Q3
$19.4K Hold
20
﹤0.01% 243
2025
Q2
$16K Sell
20
-14
-41% -$10K ﹤0.01% 252
2025
Q1
$22.5K Buy
34
+5
+17% +$3.64K 0.01% 225
2024
Q4
$20.1K Buy
29
+15
+107% +$10.8K ﹤0.01% 226
2024
Q3
$11.7K Buy
14
+4
+40% +$3.58K ﹤0.01% 264
2024
Q2
$10.2K Hold
10
﹤0.01% 249
2024
Q1
$9.71K Hold
10
﹤0.01% 246
2023
Q4
$7.57K Hold
10
﹤0.01% 258
2023
Q3
$5.89K Hold
10
﹤0.01% 265
2023
Q2
$7.25K Buy
+10
New +$6.8K ﹤0.01% 260

Other funds holding ASML

Blume Capital Management's ASML Position: Q2 2026 in Review

Blume Capital Management held its ASML (ASML) position steady in Q2 2026 at 20 shares worth $39.8K. The position accounts for 0.01% of the portfolio, ranked #216.

Blume Capital Management first reported a position in ASML in Q2 2023 and has held it in 13 quarters since. 1,450 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Blume Capital Management held 20 shares of ASML worth $39.8K as of Q2 2026.
  • Blume Capital Management left its ASML share count unchanged in Q2 2026.
  • ASML made up 0.01% of Blume Capital Management's portfolio in Q2 2026, its #216 holding.
  • Blume Capital Management first reported a position in ASML in Q2 2023 and has held it in 13 quarters since.
  • 1,450 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.